Calliditas Therapeutics AB (publ)
CLTEF · OTC
5/31/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $974 | $120 | $106 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $181 | $8 | $0 |
| Inventory | $0 | $20 | $0 | $0 |
| Other Curr. Assets | $0 | $100 | $8 | $6 |
| Total Curr. Assets | $0 | $1,275 | $135 | $112 |
| Property Plant & Equip (Net) | $0 | $54 | $3 | $4 |
| Goodwill | $0 | $49 | $4 | $4 |
| Intangibles | $3 | $431 | $42 | $40 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $51 | $0 | $0 |
| Total NC Assets | $3 | $584 | $49 | $49 |
| Other Assets | $0 | $0 | $2 | $1 |
| Total Assets | $3 | $1,859 | $187 | $161 |
| Liabilities | – | – | – | – |
| Payables | $0 | $101 | $160 | $68 |
| Short-Term Debt | $0 | $13 | $10 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $294 | -$140 | -$63 |
| Total Curr. Liab. | $0 | $407 | $31 | $15 |
| LT Debt | $0 | $967 | $84 | $45 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $151 | -$16 | -$24 |
| Total NC Liab. | $0 | $1,117 | $68 | $21 |
| Other Liabilities | $0 | $0 | $14 | $14 |
| Cap. Leases | $0 | $40 | $26 | $34 |
| Total Liabilities | $0 | $1,524 | $114 | $50 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $0 | $0 |
| Retained Earnings | -$0 | -$2,306 | -$1,836 | -$1,427 |
| AOCI | $1 | -$5 | $0 | -$27 |
| Other Equity | $0 | $2,643 | $2,602 | $2,462 |
| Total Equity | $3 | $335 | $766 | $1,008 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $26 | $1,859 | $1,953 | $1,460 |
| Net Debt | $0 | $5 | -$25 | -$51 |